← All trials
NCT04555447
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 22, 2019
- Primary completion
- Sep 7, 2019
- Completion date
- Sep 7, 2019
- First posted
- Sep 18, 2020
- Last posted
- Sep 18, 2020
- Enrollment
- 52
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Centro De Investigación Y De Estudios Avanzados Del Instituto Politécnico Nacional-Unidad IrapuatoLead sponsor
- Centro De Investigación Y De Estudios Avanzados Del Instituto Politécnico Nacional-Unidad IrapuatoReponsible party - principal investigator
- Centro de Estudios Cardiometabólicos S.C. (CESCAM)Collaborator
- National Polytechnic Institute, MexicoStudy director
- Inulina y Miel de Agave S.A. de C.V. (IMAG)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.